Previous studies found that knocking out PEBP4 could aggravate acute liver injury induced by LPS/D-GalN and liver fibrosis induced by CCl4 through the NF-κB signaling pathway [11, 12], indicating PEBP4 may be a candidate regulator for inflammatory disorders. The gene discussed is NFKB1; the disease is Hepatic fibrosis.